PrognomiQ announced the initial launch of its ProVue blood test while Mercy presented new data detailing the performance of its Halo lung cancer test.

The Galleri test, by American company GRAIL, can detect over 50 types of cancerous DNA with a simple blood test. How the cancer screening test works.

Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the US. Exceeding $200m, the deal grants Roche exclusive rights to assemble ...

Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits ...

The Cancer Check blood test screens for more than 200 types of solid tumor cancers and has detected cancer before symptoms appear, as early as Stage 0, when there is a 99% survival rate. The addition ...

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

Women now have an alternative to the Pap smear as a screening test for cervical cancer. The U.S. Food and Drug Administration on Friday approved an at-home screening test. As Reuters reported, Pap ...

We hear it over and over: early diagnosis saves lives.  No one wants to face a cancer diagnosis but suffice it to say that an ...

Cologuard is a colon cancer screening test you can do at home. It’s a noninvasive, stool-based test that comes in a kit. You use the kit to collect a stool sample. Then you send the sample to a lab ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum.